Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 1/20 | 0.67 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.67 |
| ▸ | PRKDC | P78527 | 1/20 | 0.58 |
| ▸ | LCK | P06239 | 1/20 | 0.56 |
| ▸ | FYN | P06241 | 1/20 | 0.56 |
| ▸ | MAPT | P10636 | 2/20 | 0.54 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.54 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.48 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.48 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.48 |
| ▸ | HTR2A | P28223 | 6/20 | 0.46 |
| ▸ | TAAR1 | Q96RJ0 | 3/20 | 0.46 |
| ▸ | HTR2C | P28335 | 2/20 | 0.46 |
| ▸ | ACHE | P22303 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | CA12 | O43570 | 1/20 | 0.43 |
| ▸ | CA1 | P00915 | 1/20 | 0.43 |
| ▸ | CA2 | P00918 | 1/20 | 0.43 |
| ▸ | CA7 | P43166 | 1/20 | 0.43 |
| ▸ | CA9 | Q16790 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29878552 | 1.00 | POLB (0.67) | POLBL3MBTL1PRKDCLCKFYN | |
| SCHEMBL580565 | 0.88 | POLB (0.54) | POLBL3MBTL1PRKDCLCKFYN | |
| SCHEMBL28799442 | 0.88 | POLB (0.61) | POLBL3MBTL1MAPTNPSR1HTR2A | |
| SCHEMBL30202128 | 0.88 | POLB (0.54) | POLBL3MBTL1PRKDCLCKFYN | |
| SCHEMBL298224 | 0.87 | POLB (0.59) | POLBL3MBTL1PRKDCMAPTNPSR1 | |
| SCHEMBL27143368 | 0.85 | POLB (0.52) | POLBL3MBTL1PRKDCLCKFYN | |
| SCHEMBL1505362 | 0.83 | MAPT (0.52) | POLBL3MBTL1PRKDCLCKFYN | |
| SCHEMBL16167828 | 0.83 | L3MBTL1 (0.56) | POLBL3MBTL1PRKDCLCKFYN | |
| SCHEMBL13517864 | 0.83 | L3MBTL1 (0.50) | POLBL3MBTL1PRKDCLCKFYN | |
| SCHEMBL30010118 | 0.83 | PRKDC (0.50) | POLBL3MBTL1PRKDCLCKFYN |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 82 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115785466-B | Preparation method and application of supermolecular material with green photooxidation effect | 广州大学 | 2023-08-08 | — | — | CN | claimed |
| CN-115785466-A | Preparation method and application of supramolecular material with green light oxidation effect | 广州大学 | 2023-03-14 | — | — | CN | claimed |
| JP-1283293-A | — | — | None | — | — | JP | disclosed |
| CN-119763719-A | Method for detecting isotope distribution of compound | 江苏省环境科学研究院 | 2025-04-04 | — | — | CN | disclosed |
| CN-119192031-A | Organic compound, preparation method thereof, composite material, photoelectric device and display device | 广东聚华印刷显示技术有限公司 | 2024-12-27 | — | — | CN | disclosed |
| CN-116023673-B | Preparation method of two-dimensional and three-dimensional clover-shaped metal organic supermolecule and metal organic cage | 黔南民族师范学院 | 2024-05-17 | — | — | CN | disclosed |
| US-20240092744-A1 | TRICYCLIC COMPOUND, AND PREPARATION METHOD THEREFOR AND MEDICAL USE THEREOF | THE NATIONAL INSTITUTES OF PHARMACEUTICAL R&D CO., LTD (CN) | 2024-03-21 | — | — | US | disclosed |
| CN-114981275-B | Tricyclic compound, preparation method and medical application thereof | 中国医药研究开发中心有限公司 | 2023-12-19 | — | — | CN | disclosed |
| EP-4273150-A1 | TRICYCLIC COMPOUND, AND PREPARATION METHOD THEREFOR AND MEDICAL USE THEREOF | The National Institutes of Pharmaceutical R&D Co., Ltd (CN) | 2023-11-08 | — | — | EP | disclosed |
| EP-4273150-A1 | TRICYCLIC COMPOUND, AND PREPARATION METHOD THEREFOR AND MEDICAL USE THEREOF | The National Institutes of Pharmaceutical R&D Co., Ltd (CN) | 2023-11-08 | — | — | EP | disclosed |
| CN-115785466-B | Preparation method and application of supermolecular material with green photooxidation effect | 广州大学 | 2023-08-08 | — | — | CN | disclosed |
| US-20070254185-A1 | Organic EL display device and organic thin film device | HITACHI DISPLAYS, LTD. (JP) | 2007-11-01 | — | — | US | disclosed |
| US-7244730-B2 | 2-iminopyrrolidine derivatives | EISAI CO., LTD (JP) | 2007-07-17 | — | — | US | disclosed |
| US-7244730-B2 | 2-iminopyrrolidine derivatives | EISAI CO., LTD (JP) | 2007-07-17 | — | — | US | disclosed |
| EP-1771243-A1 | POROUS ARTICLE FOR DELIVERING CHEMICAL SUBSTANCES | H.Lundbeck A/S (DK) | 2007-04-11 | — | — | EP | disclosed |
| WO-2006000227-A1 | POROUS ARTICLE FOR DELIVERING CHEMICAL SUBSTANCES | H. LUNDBECK A/S (DK) | 2006-01-05 | — | — | WO | disclosed |
| EP-0352182-B1 | OCTASUBSTITUTED LITHIUM PHTHALOCYANINES, PROCESS FOR THEIR PREPARATION AND THEIR USE IN EPR | COMMISSARIAT A L'ENERGIE ATOMIQUE (FR) | 1993-05-05 | — | — | EP | disclosed |
| US-4996311-A | Crystal structure, stability | COMMISSARIAT A. L'ENERGIE ATOMIQUE (FR) | 1991-02-26 | — | — | US | disclosed |
| EP-0352182-A1 | Octasubstituted lithium phthalocyanines, process for their preparation and their use in EPR | COMMISSARIAT A L'ENERGIE ATOMIQUE (FR) | 1990-01-24 | — | — | EP | disclosed |
| JP-H01283293-A | NOVEL METAL BISBENZOTHIOLATE COMPLEX, PRODUCTION AND SYNTHETIC INTERMEDIATE THEREOF | NOK CORP | 1989-11-14 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240092744-A1 | TRICYCLIC COMPOUND, AND PREPARATION METHOD THEREFOR AND MEDICAL USE THEREOF | GOT2, HADH, CYP4A11 | POLB 2116/4885L3MBTL1 1801/4885PRKDC 3727/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.